- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01453985
Full-Thickness-Gastroplication For The Treatment Of Gastroesophageal Reflux Disease GERD
October 14, 2011 updated by: General Public Hospital Zell am See
This is a prospective study to extensively evaluate subjective patient parameters on quality of life, reflux-symptoms, side effects, medication-use and measurements of esophageal manometry and Impedance-pH-Monitoring after Full-Thickness-Gastroplication.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Zell am See, Austria, 5700
- Recruiting
- General Public Hospital Zell am See
-
Contact:
- Oliver O Koch, MD
- Email: o.koch@sbg.at
-
Sub-Investigator:
- Oliver O Koch, MD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Description
Inclusion Criteria:
- persistent or recurrent symptoms despite continuous medical treatment, at least one typical reflux symptom (heartburn/ regurgitation/dysphagia/epigastric pain) and/or at least one atypical reflux symptom (cough/ asthma/hoarseness/distortion of taste), pathologic esophageal acid exposure as documented by a reflux-related DeMeester score ≥14.7, and symptom correlation ≥50%, and/or reflux episodes >73.
Exclusion Criteria:
- any distinct hiatal hernia detectable by gastroscopy or barium radiography, dysphagia, esophageal strictures, poor physical status (American Society of Anesthesiologists (ASA) scores III and IV) and pregnancy.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Full-Thickness-Gastroplication
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
|---|
|
Quality of Life
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Registration Dates
First Submitted
October 12, 2011
First Submitted That Met QC Criteria
October 14, 2011
First Posted (Estimate)
October 18, 2011
Study Record Updates
Last Update Posted (Estimate)
October 18, 2011
Last Update Submitted That Met QC Criteria
October 14, 2011
Last Verified
October 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Zell04
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastroesophageal Reflux Disease
-
Onconic Therapeutics Inc.Not yet recruitingNon-erosive Gastroesophageal Reflux Disease
-
TakedaTerminatedGastroesophageal Reflux Disease | Non-erosive Reflux DiseaseSwitzerland, Netherlands
-
I.M. Sechenov First Moscow State Medical UniversityActive, not recruitingGastroesophageal Reflux Disease (GERD) | Non-Erosive Gastro-Esophageal Reflux DiseaseRussia
-
Vanderbilt University Medical CenterCompletedGastroesophageal Reflux Disease (GERD) | Non-erosive Reflux Disease (NERD)United States
-
GlaxoSmithKlineCompletedReflux, Gastroesophageal | Gastroesophageal Reflux DiseaseAustralia
-
King Chulalongkorn Memorial HospitalCompleted
-
Mansoura UniversityWithdrawnGastroesophageal Reflux Disease
-
Cliniques universitaires Saint-Luc- Université...UnknownGastroesophageal Reflux DiseaseBelgium
-
Medical College of WisconsinNot yet recruitingGastroesophageal Reflux Disease | Refractory Gastroesophageal Reflux DiseaseUnited States
-
Cinclus Pharma Holding ABWithdrawn
Clinical Trials on Full-Thickness-Gastroplication
-
Technical University of MunichUnknownAtypical Gastroesophageal Reflux Symptoms | Objectified Gastroesophageal Reflux DiseaseAustria, Germany
-
Indiana UniversityRecruiting
-
Semmelweis UniversityInstitut Straumann AG; Geistlich Pharma AG; Dicomlab Kft.Recruiting
-
NDO Surgical, Inc.Terminated
-
Assistance Publique - Hôpitaux de ParisTerminated
-
NDO Surgical, Inc.Terminated
-
NDO Surgical, Inc.CompletedGastroesophageal Reflux Disease (GERD)United States, Canada
-
NDO Surgical, Inc.Completed
-
Kliniken Ludwigsburg-Bietigheim gGmbHOvesco Endoscopy AGUnknownColorectal Adenomas | Submucosal TumorsGermany
-
Chinese University of Hong KongRecruiting